PhoenixBio Co.,Ltd. Logo

PhoenixBio Co.,Ltd.

A CRO providing humanized liver mouse models for preclinical drug studies.

6190 | T

Overview

Corporate Details

ISIN(s):
JP3803010002
LEI:
Country:
Japan
Address:
東広島市鏡山三丁目4番1号

Description

PhoenixBio is a contract research organization (CRO) specializing in translational animal models for the pharmaceutical industry. The company's core product is the PXB-mouse®, a proprietary chimeric mouse model featuring a liver that is highly repopulated (over 70%) with functional human hepatocytes. This humanized liver model is utilized globally in preclinical studies to evaluate drug metabolism, pharmacokinetics, and toxicity. In addition to supplying the PXB-mouse® and primary human hepatocytes (PXB-cells®), PhoenixBio provides comprehensive, quality-controlled contract study services to support drug discovery and early development projects.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-14 08:12
確認書
Japanese 8.1 KB
2025-11-14 08:10
半期報告書-第25期(2025/04/01-2026/03/31)
Japanese 163.4 KB
2025-07-01 04:29
臨時報告書
Japanese 22.2 KB
2025-06-25 04:07
内部統制報告書-第24期(2024/04/01-2025/03/31)
Japanese 22.3 KB
2025-06-25 04:04
確認書
Japanese 8.0 KB
2025-06-25 04:02
有価証券報告書-第24期(2024/04/01-2025/03/31)
Japanese 912.3 KB
2025-05-23 05:02
臨時報告書
Japanese 19.1 KB
2025-05-14 09:55
臨時報告書
Japanese 20.1 KB
2025-03-03 02:24
臨時報告書
Japanese 19.0 KB
2024-11-14 08:06
確認書
Japanese 8.0 KB
2024-11-14 08:04
半期報告書-第24期(2024/04/01-2025/03/31)
Japanese 165.5 KB
2024-07-02 02:35
臨時報告書
Japanese 18.4 KB
2024-07-01 07:59
臨時報告書
Japanese 21.4 KB
2024-06-27 03:06
内部統制報告書-第23期(2023/04/01-2024/03/31)
Japanese 22.1 KB
2024-06-27 03:04
確認書
Japanese 8.0 KB

Automate Your Workflow. Get a real-time feed of all PhoenixBio Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PhoenixBio Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PhoenixBio Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Pre-clinical biotech company using AI for drug discovery and biodefense.
United States of America
RENB
LYSOGENE Logo
A former clinical-stage biotech that developed gene therapies for rare CNS diseases.
France
LYS
MaaT Pharma Logo
A clinical-stage biotech developing microbiome-based therapeutics for oncology.
France
MAAT
Matinas BioPharma Holdings, Inc. Logo
Biopharma firm developing therapeutics using its Lipid Nanocrystal (LNC) platform.
United States of America
MTNB
Matricelf Ltd. Logo
Develops autologous, patient-specific tissue implants for regenerative medicine.
Israel
MTLF
MAXCYTE, INC. Logo
A cell-engineering company with a platform for developing cell-based therapeutics.
United States of America
MXCT
Medicofarma Biotech Spolka Akcyjna Logo
R&D company developing innovative medicines, medical devices, and biotech products.
Poland
MDB
Medigene AG Logo
Develops TCR-guided immunotherapies for cancer; currently in insolvency proceedings.
Germany
MDG1
Medizen Humancare Inc Co., Ltd Logo
A research company specializing in genomic analysis for personalized healthcare.
South Korea
236340
Medpace Holdings, Inc. Logo
A global CRO providing Phase I-IV clinical development for biotech and pharma industries.
United States of America
MEDP

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.